当前位置:公众访问 >页面
简体中文 / English
.
1.Screening
1.1.group
1.2.Inclusion Criteria

Age 55~80 years

Date of signature

yyyy-mm-dd

The patients agreed to participate in the trial and signed the informed consent

The volume of the prostate was less than 150ml

Male,Was diagnosed as benign prostatic hyperplasia, and need surgical treatment

1.3.Exclusion Criteria

there is operation contraindications of transurethral prostatic hyperplasia resection according to the CUA guidelines

2.Baseline
2.1.Management for Progress(B)
2.2.General information
2.3.Physical examination
2.4.Blood Routine Tests
2.5.Urine and Stool Routine Tests
2.6.Blood Electrolytes Tests
2.7.Coagulation Function Tests
2.8.Serum Liver Function Tests
2.9.HBV Markers Test
2.10.Renel Function Test
2.11.Heat Function Examination
2.12.Blood Cell Morphology
2.13.Image Examinations
2.14.Nervous System Examination
2.15.Lung Function Examination
2.16.Blood Gas Analysis
2.17.Physical Ability Examination
2.18.Health Relative Quality of Life
3.In the process of the treatment
3.1.Treatment Record
4.At the end of the treatment
4.1.Management for Progress
4.2.Physical examination
4.3.Blood Routine Tests
4.4.Urine and Stool Routine Tests
4.5.Serum Electrolytes Tests
4.6.Liver Function Tests
4.7.HBV Markers Test
4.8.Renel Function Test
4.9.Heat Function Examination
4.10.Image Examinations
4.11.Blood Cell Morphology
4.12.Nervous System Examination
4.13.Lung Function Examination
4.14.Blood Gas Analysis
4.15.Physical Sbility Examination
4.16.Health Relative Quality of Life
5.Follow-up 1
5.1.IPSS
5.2.QOL
5.3.IIEF-5
5.4.Qmax

Qmax

6.Follow-up 2
7.Follow-up 3